Oppenheimer Maintains Outperform on Pulse Biosciences, Raises Price Target to $60
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Oppenheimer analyst Suraj Kalia maintains Pulse Biosciences (NASDAQ:PLSE) with a Outperform and raises the price target from $35 to $60.
Oppenheimer analyst Suraj Kalia maintains Pulse Biosciences (NASDAQ:PLSE) with a Outperform and raises the price target from $35 to $60.